Back to company

Tissue-Link ApS: Financial statements 2024

CVR: 40633979

Tissue-Link ApS (CVR 40633979) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -398,670 and a net result of DKK -319,133 compared with DKK 5,830 the year before. Equity amounted to DKK -81,893.

Gross Profit
-398,670 kr.
Profit/Loss
-319,133 kr.
Equity
-81,893 kr.
Total Assets
1,396,877 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--399 t.-319 t.-82 t.-
2023-17 t.6 t.237 t.-
2022--231 t.-184 t.231 t.-
2021-367 t.326 t.415 t.-
2020--214 t.-189 t.89 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Tissue-Link ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Kurt Bækgaard Osther leaves the board of Tissue-Link ApSMar 7, 2024

As of March 7, 2024, Kurt Bækgaard Osther has left the board of directors of Tissue-Link ApS.

Pär Ingemar Johansson leaves the board of Tissue-Link ApSMar 7, 2024

As of March 7, 2024, Pär Ingemar Johansson has left the board of directors of Tissue-Link ApS.

Lars Ploug Hansen joins the board of Tissue-Link ApSFeb 16, 2024

As of February 16, 2024, Lars Ploug Hansen has joined the board of directors of Tissue-Link ApS.

Niels Ole Mikkelsen joins the board of Tissue-Link ApSFeb 16, 2024

As of February 16, 2024, Niels Ole Mikkelsen has joined the board of directors of Tissue-Link ApS.

Tissue-Link ApS: The 2023 annual report is outFeb 9, 2024

Tissue-Link ApS has published its annual report for 2023. Gross profit came to DKK 16,551, and the net result was DKK 5,830.

About Tissue-Link ApS

Tissue-Link ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Aadal Nielsen. The company's owners include Kurt Bækgaard Osther, AADALBIOTECH ApS and LGM WINTHER HOLDING ApS. In 2025, the company reported a gross profit of DKK -818,426 and a net result of DKK -771,522 compared with DKK -319,133 the year before. Equity amounted to DKK -853,415.

Other financial years